Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Pozycja w akcjach #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Cena akcji
$0.0202
Ostatnia synchronizacja: 2024-11-19
Kapitalizacja rynkowa
$44.67K
Zmiana (1 dzień)
-0.49%
Zmiana (1 rok)
0.00%
Kraj
IL
Handel Notable Labs, Ltd. (NTBL)

Kategoria

Wskaźnik P/B dla Notable Labs, Ltd. (NTBL)
Wskaźnik P/B na dzień August 2026 TTM: 0.04
Według najnowszych raportów finansowych i ceny akcji Notable Labs, Ltd., obecny wskaźnik P/B (TTM) wynosi 0.04. Na koniec 2022 wynosił -0.25.
Historia wskaźnika P/B dla Notable Labs, Ltd. od 2015 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) 0.04 -86.41%
2023 0.27 -208.34%
2022 -0.25 -99.73%
2021 -93.37 -186.36%
2020 108.12 83.51%
2019 58.92 179.46%
2018 21.08 -82.69%
2017 121.80 21.83%
2016 99.97 -6.40%
2015 106.81 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
6.2613 16,960.76%
US
6.3483 17,197.82%
NL
- -
CH
- -
KR
3.634 9,801.91%
BE